-
1
Neurofilament light as a blood biomarker for neurodegeneration in down syndrome
Published 2018“…Conclusions NF-L is a biomarker for neurodegeneration in DS with potential for use in future clinical trials to prevent or delay dementia.…”
Get full text
Get full text
Journal Article -
2
MED13 and glycolysis are conserved modifiers of α-synuclein-associated neurodegeneration
Published 2023“…The resulting neurodegeneration can be suppressed by overexpressing a glycolytic enzyme or treatment with deferoxamine, suggesting that compensatory glycolysis is neuroprotective. …”
Get full text
Journal Article -
3
Amyloid-tau-neurodegeneration profiles and longitudinal cognition in sporadic young-onset dementia
Published 2023“…We examined amyloid-tau-neurodegeneration biomarker effects on cognition in a Southeast-Asian cohort of 84 sporadic young-onset dementia (YOD; age-at-onset <65 years) patients. …”
Get full text
Journal Article -
4
The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesis
Published 2023Subjects: Get full text
Journal Article -
5
Brief report : isogenic induced pluripotent stem cell lines from an adult with mosaic down syndrome model accelerated neuronal ageing and neurodegeneration
Published 2015“…DS is also a unique genetic system for investigation of pathological and protective mechanisms for accelerated ageing, neurodegeneration, dementia, cancer, and other important common diseases. …”
Get full text
Get full text
Journal Article -
6
Mitochondrial regulation of microglial immunometabolism in Alzheimer’s disease
Published 2021Subjects: Get full text
Journal Article -
7
High diagnostic utility incorporating a targeted neurodegeneration gene panel with MRI brain diagnostic algorithms in patients with young-onset cognitive impairment with leukodystrophy
Published 2021“…We performed sequencing using a custom-designed panel of 200 neurodegeneration-associated genes on 45 patients with young-onset cognitive impairment with leukodystrophy, and classified them based on van der Knaap et al.'…”
Get full text
Journal Article -
8
Longitudinal analysis of retinal microvascular and choroidal imaging parameters in Parkinson's disease compared with controls
Published 2024Subjects: Get full text
Journal Article -
9
Defective lysosomal acidification: a new prognostic marker and therapeutic target for neurodegenerative diseases
Published 2023“…Similar lysosomal abnormalities are also present in sporadic forms of neurodegeneration, although the underlying pathogenic mechanisms are unclear and remain to be investigated. …”
Get full text
Journal Article -
10
Methylene blue inhibits Caspase-6 activity, and reverses Caspase-6-induced cognitive impairment and neuroinflammation in aged mice
Published 2021“…Mice expressing human Caspase-6 in hippocampal CA1 neurons develop age-dependent cognitive deficits, neurodegeneration and neuroinflammation. This study assessed if methylene blue (MB), a phenothiazine that inhibits caspases, alters Caspase-6-induced neurodegeneration and cognitive impairment in mice. …”
Get full text
Journal Article -
11
Misfolded protein linked strategies toward biomarker development for neurodegenerative diseases
Published 2021“…The genetic and molecular origins of protein misfolding in association with their relationship with neurodegeneration and aging are being studied to better understand and develop treatments. …”
Get full text
Journal Article -
12
Current and future trends in biomarkers for the early detection of Alzheimer's disease in Asia: expert opinion
Published 2024“…The amyloid, tau, and neurodegeneration (AT[N]) framework, which classifies biomarkers by their core pathophysiological features, is a biomarker measure of amyloid plaques and neurofibrillary tangles. …”
Get full text
Journal Article -
13
Autolysosomal acidification impairment as a mediator for TNFR1 induced neuronal necroptosis in Alzheimer's disease
Published 2024“…By combining features of apoptosis and necrosis, necroptosis has been proposed to constitute a more comprehensive mechanistic explanation for neurodegeneration, which is less likely to occur by the immunologically silent apoptotic cell death or by the acute occurrence of necrosis after cellular stress (Jayaraman and Reynolds, 2022).…”
Get full text
Journal Article -
14
Activation of autophagy ameliorates age-related neurogenesis decline and neurodysfunction in adult mice
Published 2022“…However, this process declines with aging, which is implicated in the recession of brain function and neurodegeneration. Understanding the mechanism of adult neurogenesis and stimulating neurogenesis will benefit the mitigation of neurodegenerative diseases. …”
Get full text
Journal Article -
15
A pair of siblings with Wolfram Syndrome: a review of the literature and treatment options
Published 2023“…Wolfram syndrome (WS) is a rare genetic disorder typically characterized by juvenile onset diabetes mellitus, optic atrophy, hearing loss, diabetes insipidus, and neurodegeneration. There would be a high index of clinical suspicion for WS when clinical manifestations of type 1 diabetes and optic atrophy present together. …”
Get full text
Journal Article -
16
The small molecule AUTEN-99 (autophagy enhancer-99) prevents the progression of neurodegenerative symptoms
Published 2017“…Defects in autophagy are implicated in the development of various age-dependent degenerative disorders such as cancer, neurodegeneration and tissue atrophy, and in accelerated aging. …”
Get full text
Get full text
Journal Article -
17
Mitochondrial dysfunction and Parkinson’s disease — near-infrared photobiomodulation as a potential therapeutic strategy
Published 2021“…A recent approach towards forestalling dopaminergic neurodegeneration in PD involves near-infrared (NIR) photobiomodulation (PBM), which is thought to enhance mitochondrial function of stimulated cells through augmenting the activity of cytochrome C oxidase. …”
Get full text
Journal Article -
18
In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [18F]MNI-659
Published 2021“…Highly specific and sensitive biomarkers for pathologies related to dysfunctions in the basal ganglia circuit are of great value to assess therapeutic efficacy not only clinically to establish an early diagnosis, but also in terms of monitoring the efficacy of therapeutic interventions and decelerated neurodegeneration. The phosphodiesterase 10A (PDE10A) enzyme plays a central role in striatal signaling and is implicated in several neuropsychiatric disorders involving striatal pathology, such as Huntingtońs disease (HD) and schizophrenia. …”
Get full text
Journal Article -
19
Differential effects of white matter hyperintensities and regional amyloid deposition on regional cortical thickness
Published 2022“…White matter hyperintensities (WMH) and β-amyloid (Aβ) accumulation have both been linked to neurodegeneration in Alzheimer's disease (AD). However, the independent effects of global WMH and regional Aβ on the corresponding regional cortical thickness have not been investigated. …”
Get full text
Journal Article -
20
Lewy body-like inclusions in human midbrain organoids carrying glucocerebrosidase and α-synuclein mutations
Published 2022“…Objective: We utilized human midbrain-like organoids (hMLOs) generated from human pluripotent stem cells carrying glucocerebrosidase gene (GBA1) and α-synuclein (α-syn; SNCA) perturbations to investigate genotype-to-phenotype relationships in Parkinson disease, with the particular aim of recapitulating α-syn– and Lewy body–related pathologies and the process of neurodegeneration in the hMLO model. Methods: We generated and characterized hMLOs from GBA1−/−and SNCA overexpressing isogenic embryonic stem cells and also generated Lewy body–like inclusions in GBA1/SNCA dual perturbation hMLOs and conduritol-b-epoxide–treated SNCA triplication hMLOs. …”
Get full text
Journal Article